Funding
Series A1 · Biotech

Caldera Therapeutics raises $37.5M Series A1

Caldera Therapeutics raised $37.5 million in Series A1 financing announced in January.

Updated Oct 16, 2026By RoundOS Funding desk

Omega Funds, LAV, venBio, Wellington Management and Janus Henderson Investors are among its backers.

The company develops the bispecific antibody CLD-423 for inflammatory bowel disease.

Funding history

Series A1 · This round$37.5M

Sources

  1. Caldera Therapeuticsprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related